Stilla Technologies Stilla Technologies Adds dPCR Oncology Menu, End Users as Part of Clinical Pivot Premium The firm is seeing the fruit of a two-year investment in transitioning from a research lab to a clinical focus. Breaking News EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's Clasp Therapeutics Initiates Phase I Trial of T-Cell Engager AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test Craif Raises $22M in Series C Round to Expand US, Japan Operations CHMP Issues Positive Recommendation for Jazz Pharmaceuticals' Ziihera
